The Mission Bay Capital team has deep collective experience investing in and building companies.
Regis B. Kelly, PhDMBC PartnerDirector, QB3Prior to joining QB3 in 2004, Dr. Kelly served as executive vice-chancellor at UCSF; he oversaw the UCSF research enterprise and was also responsible for construction of the new Mission Bay campus. He is currently chairman of the Bay Area Scientific Innovation Consortium and has served on the boards of the Malaysian Biotechnology Industry Advisory Board, the Scleroderma Foundation, and Bridge Pharmaceuticals. He is an advisor to the Thailand Bionanotechnology Institute, Ho Chi Minh City Biotechnology Department Corp., University of Oxford Systems Biology Program, and the San Francisco Mayor’s Biotechnology Advisory Group. He joined the UCSF Department of Biochemistry in 1971 and has served as the University’s Director of Cell Biology Graduate Program, the Director of the Hormone Research Institute, and Chair of the Department of Biochemistry and Biophysics. He earned an undergraduate degree in physics from the University of Edinburgh and a PhD in biophysics from the California Institute of Technology. |
|
Douglas Crawford, PhDMBC PartnerAssociate Director, QB3Douglas Crawford’s goal is to help stimulate economic growth in California by promoting cross-discipline academic research and accelerating the transfer of the resulting innovations to the market. Crawford created and manages the first incubator within the University of California, the QB3 Garage@UCSF, which has now expanded to include the QB3 Garage@Berkeley, the QB3 Mission Bay Innovation Center, and the QB3 East Bay Innovation Center. Together these incubators are currently home to 42 companies. Crawford is also a founder and managing director of Mission Bay Capital, an $11.3M seed-stage venture fund that seeks to make pivotal early-stage investments in bioscience companies emerging from UC. He is a board member of Redwood Biosciences (observer), Delpor, and the BayBio Institute. Crawford received his PhD in biochemistry from UCSF. Email: douglas.crawford@missionbaycapital.com |
Neena Kadaba, PhDMBC PartnerDirector, Industry Alliances, QB3Neena Kadaba works to initiate new collaborations between industry and QB3 campus scientists and manages QB3’s multi-year, multimillion dollar alliance with Pfizer. She runs the Quadrant industry speakers seminar series to link scientists from industry to scientists in academia and startups, writes the quadrant@qb3 newsletter focused on highlighting innovation at the QB3 campuses, and manages QB3’s internship program. Previously, she co-founded Cypress Innovations and was an associate and Kauffman Fellow in the venture capital group at Itochu Technology. She earned her BS at the Massachusetts Institute of Technology and her PhD in chemistry at the California Institute of Technology. |